B
Bull
Bull · 25%RVP
$0.71
Precio del escenario
$0.720
-0.012 (-1.64%)Al cierre
Loading chart…
- High
- 0.735
- Open
- 0.700
- VWAP
- 0.72
- Vol
- 15.47K
- Mkt Cap
- 32.63M
- Low
- 0.717
- Amount
- 11.20K
- EV/EBITDA, TTM
- 0.00
Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
AI analysis of Retractable Technologies Inc (RVP)
holdRetractable Technologies Inc (RVP) is currently priced at 0.73, with an RSI of 68.133 indicating it is approaching overbought territory. While the gross margin has dramatically improved to 90.85% in Q2 2026, the company also faces risks with a net loss of 4.28 million in Q1 2026 and a significant year-over-year sales decline of 13.3%.
Métricas de valoración
The current forward P/E ratio for Retractable Technologies Inc (RVP) is 0.00, compared to its 5-year average forward P/E of 0.00.
Alphio AI Price Scenarios for RVP
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Cronología de eventos
Noticias
9.508-14NewsfilterRetractable Technologies Reports Q2 2026 Financial Results
- 8.006-30Newsfilter
Retractable Technologies Declares Dividends for Convertible Preferred Stock
9.505-15seekingalphaRetractable Technologies Q1 Financial Results
- 9.505-15Newsfilter
Retractable Technologies Reports Q1 Financial Results
- 5.004-09Newsfilter
Retractable Technologies Cuts 16% Workforce to Save Costs
RVP FAQ — answered by Alphio AI
Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Retractable Technologies Inc (RVP) is currently priced at 0.73, with an RSI of 68.133 indicating it is approaching overbought territory. While the gross margin has dramatically improved to 90.85% in Q2 2026, the company also faces risks with a net loss of 4.28 million in Q1 2026 and a significant year-over-year sales decline of 13.3%.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.